M. Varroud‐Vial

660 total citations
23 papers, 510 citations indexed

About

M. Varroud‐Vial is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Varroud‐Vial has authored 23 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 8 papers in General Health Professions and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Varroud‐Vial's work include Diabetes Management and Education (7 papers), Health, Medicine and Society (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). M. Varroud‐Vial is often cited by papers focused on Diabetes Management and Education (7 papers), Health, Medicine and Society (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). M. Varroud‐Vial collaborates with scholars based in France, India and United States. M. Varroud‐Vial's co-authors include G. Charpentier, Serge Herçberg, Christian Vaisse, Philippe Froguel, B Guy-Grand, Karine Clément, Pilar Galán, Alan R. Shuldiner, François Ledru and N Danchin and has published in prestigious journals such as Diabetes Care, International Journal of Obesity and Drugs.

In The Last Decade

M. Varroud‐Vial

23 papers receiving 485 citations

Peers

M. Varroud‐Vial
Shamasunder Acharya Australia
Jeong‐Ah Shin South Korea
C. G. Östenson Sweden
Doo Man Kim South Korea
Rosângela Réa Brazil
Lucianne Righeti Monteiro Tannus Brazil
B. T. Srinivasan United Kingdom
Thavatchai Peerapatdit Thailand
Pamela Kushner United States
Diana Glovaci United States
Shamasunder Acharya Australia
M. Varroud‐Vial
Citations per year, relative to M. Varroud‐Vial M. Varroud‐Vial (= 1×) peers Shamasunder Acharya

Countries citing papers authored by M. Varroud‐Vial

Since Specialization
Citations

This map shows the geographic impact of M. Varroud‐Vial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Varroud‐Vial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Varroud‐Vial more than expected).

Fields of papers citing papers by M. Varroud‐Vial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Varroud‐Vial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Varroud‐Vial. The network helps show where M. Varroud‐Vial may publish in the future.

Co-authorship network of co-authors of M. Varroud‐Vial

This figure shows the co-authorship network connecting the top 25 collaborators of M. Varroud‐Vial. A scholar is included among the top collaborators of M. Varroud‐Vial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Varroud‐Vial. M. Varroud‐Vial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varroud‐Vial, M.. (2011). Improving diabetes management with electronic medical records. Diabetes & Metabolism. 37. S48–S52. 12 indexed citations
2.
Varroud‐Vial, M.. (2011). Le parcours de soin : une solution ou une contrainte supplémentaire ?. Médecine des Maladies Métaboliques. 5. S81–S85. 1 indexed citations
3.
Charbonnel, B, et al.. (2011). Insulin therapy for diabetes mellitus: Treatment regimens and associated costs. Diabetes & Metabolism. 38(2). 156–163. 20 indexed citations
4.
Fagot‐Campagna, A., et al.. (2010). Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM–SFC 2004 Guidelines in a population of diabetic patients. Diabetes & Metabolism. 36(4). 286–292. 2 indexed citations
5.
Franc, Sylvia, et al.. (2010). Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy. Diabetes & Metabolism. 36(3). 229–233. 9 indexed citations
6.
Varroud‐Vial, M., et al.. (2010). 165 Annual review of type 2 diabetes—results of a national program. A12–A13. 1 indexed citations
7.
Franc, Sylvia, Dured Dardari, Jean‐Pierre Riveline, et al.. (2010). Can Postprandial Blood Glucose Excursion Be Predicted in Type 2 Diabetes?. Diabetes Care. 33(9). 1913–1918. 17 indexed citations
8.
Franc, Sylvia, Dured Dardari, Catherine Petit, et al.. (2009). Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients. Diabetes & Metabolism. 35(6). 463–468. 40 indexed citations
9.
10.
Weill, Alain, et al.. (2008). French medical practice in type 2 diabetes: The need for better control of cardiovascular risk factors. Diabetes & Metabolism. 34(1). 38–45. 24 indexed citations
11.
12.
Varroud‐Vial, M., et al.. (2008). P118 Premiers résultats du réseau Diabiroise dans le suivi des diabétiques : analyse des bilans annuels disponibles au 31-8-2007. Diabetes & Metabolism. 34. H76–H76. 1 indexed citations
13.
Varroud‐Vial, M., et al.. (2007). Les réseaux de santé Diabète : quel bilan ? quel avenir ?. Médecine des Maladies Métaboliques. 1(2). 75–79. 1 indexed citations
14.
Charpentier, G., Jean‐Pierre Riveline, Dured Dardari, & M. Varroud‐Vial. (2006). Should Postprandial Hyperglycaemia in Prediabetic and Type 2 Diabetic Patients be Treated?. Drugs. 66(3). 273–286. 12 indexed citations
15.
Varroud‐Vial, M., D. Simon, JR Attali, et al.. (2004). Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme. Diabetic Medicine. 21(6). 592–598. 33 indexed citations
16.
Danchin, N, et al.. (2003). Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications. Diabetes & Metabolism. 29(3). 207–222. 50 indexed citations
17.
Varroud‐Vial, M., G. Charpentier, L Vaur, et al.. (2001). Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study.. PubMed. 27(6). 666–74. 9 indexed citations
18.
Clément, Karine, Serge Herçberg, Pilar Galán, et al.. (2000). The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. International Journal of Obesity. 24(3). 391–393. 117 indexed citations
19.
Charpentier, G., et al.. (2000). Management of drugs affecting blood glucose in diabetic patients with renal failure.. PubMed. 26 Suppl 4. 73–85. 108 indexed citations
20.
Varroud‐Vial, M., et al.. (1999). Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.. PubMed. 25(1). 55–63. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shamasunder Acharya Breakdown of academic impact, for papers by Jeong‐Ah Shin Breakdown of academic impact, for papers by C. G. Östenson Breakdown of academic impact, for papers by Doo Man Kim Breakdown of academic impact, for papers by Rosângela Réa Breakdown of academic impact, for papers by Lucianne Righeti Monteiro Tannus Breakdown of academic impact, for papers by B. T. Srinivasan Breakdown of academic impact, for papers by Thavatchai Peerapatdit Breakdown of academic impact, for papers by Pamela Kushner Breakdown of academic impact, for papers by Diana Glovaci
Rankless by CCL
2026